| |||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
Asthma (Lyprinol®) |
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
Because green-lipped mussel is not an essential nutrient, deficiencies do not occur.
The studies on green-lipped mussel have used 210 mg per day of the lipid extract or 1,050–1,150 mg per day of the freeze-dried powder.
Not all studies have demonstrated side effects; however, members of the Australian Rheumatism Association have reported side effects, such as stomach upset, gout, and skin rashes, occurring in people taking certain New Zealand green-lipped mussel extracts.13 Another researcher observed nausea, flatulence, and fluid retention in some of the study participants,14 and one case of hepatitis has been reported in association with the use of the substance.15
People with shellfishallergy should consult a doctor before taking green-lipped mussel. Compared to lipid preparations, freeze-dried preparations contain substantially more of the protein fraction responsible for allergic reactions.
At the time of writing, there were no well-known drug interactions with green-lipped mussel.
1. Gursel T, Firat S, Ercan ZS. Increased serum leukotriene B4 level in the active stage of rheumatoid arthritis in children. Prostaglandins Leukot Essent Fatty Acids 1997;56:205-7.
2. Henderson WR Jr. The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-97.
3. Larkin JG, Capell HA, Sturrock RD. Seatone in rheumatoid arthritis: a six-month placebo-controlled study. Ann Rheum Dis 1985;44:199-201.
4. Highton TC, McArthur AW. Pilot study on the effect of New Zealand Green Mussel on rheumatoid arthritis. N Z Med J 1975;81:261-2.
5. Gibson RG, Gibson SL, Conway V, et al. Perna canaliculus in the treatment of arthritis. Practitioner 1980;224:955-60.
6. Audeval B, Bouchacourt P. Etude controle en double aveugle contra placebo de l’extrait de moule Perna canaliculus dans les gonarthrose. Gaz Med Fr 1986;38:111-6.
7. Caughey DE, Grigor RR, Caughey EB, et al. Perna canaliculus in the treatment of rheumatoid arthritis. Eur J Rheumatol Inflamm 1983;6:197-200.
8. Gibson SLM, Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Comp Ther Med 1998;6:122-6.
9. Gibson RG, Gibson SL. Green-lipped mussel extract in arthritis. Lancet 1981;1:439 [letter].
10. Whitehouse MW, Marcides TA, Kalafatis N, et al. Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green lipped muscle. Inflam Pharmacol 1997:5:237-46.
11. Rainsford KD, Whitehouse MW. Gastroprotective and anti-inflammatory properties of green-lipped mussel preparation. Arzneimittelforschung 1980;30:2128-32.
12. Emelyanov A, Fedoseev G, Krasnoschekova O, et al. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002;20:596–600.
13. Brooks PM. Side effects from Seatone. Med J Aust 1980;2:158 [letter].
14. Gibson SLM, Gibson RG. The treatment of arthritis with a lipid extract of Perna canaliculus: a randomized trial. Comp Ther Med 1998;6:122–6.
15. Brooks PM. Side effects from Seatone. Med J Aust 1980;2:158 [letter].
| |||||||